Journal
HISTOPATHOLOGY
Volume 59, Issue 4, Pages 763-775Publisher
WILEY
DOI: 10.1111/j.1365-2559.2011.03993.x
Keywords
cancer stem cells; CD133; GFAP; glioma; Nanog; Oct4; Sox2
Categories
Funding
- National Basic Research Program of China (973 Program) [2007CB512001, 2011CB966201]
- National Natural Science Foundation of China [30771142, 81071057]
- Natural Science Foundation of Shandong Province [Z2007C11, JQ200823]
Ask authors/readers for more resources
Aims: To investigate whether Oct4, Sox2 and Nanog, three core regulatory factors maintaining pluripotency and self-renewal of embryonic stem cells (ESCs), are coexpressed in human gliomas, and whether their expression might be linked to carcinogenesis and the formation of cancer stem cells (CSCs). Methods and results: Forty cases of human glioma were examined. The expression of Oct4, Sox2 and Nanog was analysed by immunohistochemistry, reverse transcription polymerase chain reaction and western blot. We found a positive correlation between the expression levels of Oct4, Sox2 and Nanog and tumour malignancy. Immunohistochemistry showed that Oct4 and Nanog were expressed in both the nuclei and the cytoplasm of glioma cells, whereas Sox2 was expressed only in the nuclei. Double immunofluorescence staining revealed that a majority of Oct4-positive cells coexpressed Sox2 and Nanog. More than 50% of Oct4-positive cells coexpressed the putative CSC markers CD133 and Nestin. Moreover, some cells exhibited Oct4 and Nanog immunoexpression in the cytoplasm, but the frequency of positive cells did not correlate with tumour malignancy. Conclusions: The present findings suggest that ESC-associated pathways are activated in human gliomas and that these may be involved in glioma progression, a role that is distinct from that in ESCs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available